SCHEMBL8006575

SCHEMBL8006575

CCCCCCCCCCCCCCNCC(O)CCCCCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 6/20 0.54
TNF P01375 4/20 0.54
PDE4A P27815 4/20 0.54
PDE4B Q07343 3/20 0.54
PDE4C Q08493 3/20 0.54
PDE4D Q08499 3/20 0.54
CYP1A2 P05177 3/20 0.54
PMP22 Q01453 3/20 0.54
LMNA P02545 2/20 0.54
NFKB1 P19838 2/20 0.54
ACHE P22303 2/20 0.54
USP2 O75604 1/20 0.54
TSHR P16473 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
RXFP1 Q9HBX9 1/20 0.54
ADORA2A P29274 2/20 0.51
BLM P54132 2/20 0.48
ESR1 P03372 1/20 0.48
MAPT P10636 1/20 0.48
CHIT1 Q13231 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8006003 1.00 ADORA2B (0.54) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL7604975 1.00 ADORA2B (0.54) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL8378556 1.00 ADORA2B (0.54) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL8695168 1.00 ADORA2B (0.54) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL8375264 1.00 ADORA2B (0.54) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL8378526 1.00 ADORA2B (0.54) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL8376094 1.00 ADORA2B (0.54) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL8697911 1.00 ADORA2B (0.54) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL8005651 1.00 ADORA2B (0.54) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL8375960 1.00 ADORA2B (0.54) ADORA2BTNFPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5670507-A Method for reversing multiple drug resistant phenotype CELL THERAPEUTICS, INC. (US) 1997-09-23 US claimed
US-6100271-A Therapeutic compounds containing xanthinyl CELL THERAPEUTICS, INC. (US) 2000-08-08 US disclosed
US-6043250-A Methods for using therapeutic compounds containing xanthinyl CELL THERAPEUTICS, INC. (US) 2000-03-28 US disclosed
US-5929081-A ADMINISTERING COMPOUND THAT INHIBITS SIGNAL TRANSDUCTION THROUGH CELLULAR ACCUMULATION OF NON-ARACHIDONYL PHOSPHATIDIC ACID CELL THERAPEUTICS INC. (US) 1999-07-27 US disclosed
US-5859018-A ANTIARTHRITIC AGENTS; ANTITUMOR AGENTS; CARDIOVASCULAR DISORDERS CELL THERAPEUTICS, INC. (US) 1999-01-12 US disclosed
US-5856331-A LYSOPHOSPHATIDIC ACYLTRANSFERASE INHIBITOR CELL THERAPEUTICS, INC. (US) 1999-01-05 US disclosed
US-5837703-A AUTOIMMUNE DISEASES, ARTHRITIS, CANCER, LEUKEMIA, MULTIPLE SCLEROSIS; ANTITUMOR AGENTS CELL THERAPEUTICS, INC. (US) 1998-11-17 US disclosed
US-5824677-A SUBSTITUTED WITH HETEROCYCLIC RING, ANTIINFLAMMATORY, IMMUNOSUPPRESSIVE CELL THERAPEUTICS, INC. (US) 1998-10-20 US disclosed
US-5807862-A Therapeutic compounds containing pyrimidinyl moieties CELL THERAPEUTICS, INC. (US) 1998-09-15 US disclosed
US-5801181-A Amino alcohol substituted cyclic compounds CELL THERAPEUTICS, INC. (US) 1998-09-01 US disclosed
US-5795898-A ANTITUMOR, ANTICANCER AGENTS, ANTIDIABETIC AGENTS, SKIN DISORDERS CELL THERAPEUTICS, INC. (US) 1998-08-18 US disclosed
US-5777117-A ANTIINFLAMMATORY, IMMUNOSUPPRESSIVE, CYTOTOXIC AGENTS; MICROBIOCIDES, FUNGICIDES CELL THERAPEUTICS, INC. (US) 1998-07-07 US disclosed
US-5750575-A ANTIINFLAMMATORY AGENTS; IMMUNOSUPPRESSANTS; CYTOTOXIC AGENTS; MICROBIOCIDES; FUNGICIDES CELL THERAPEUTICS, INC. (US) 1998-05-12 US disclosed
US-5670507-A Method for reversing multiple drug resistant phenotype CELL THERAPEUTICS, INC. (US) 1997-09-23 US disclosed
US-5641783-A ANTIINFLAMMATORY OR IMMUNOSUPPRESSIVE AGENTS CELL THERAPEUTICS, INC. (US) 1997-06-24 US disclosed
EP-0719267-A1 SECOND MESSENGER CELL SIGNALING INHIBITORS CELL THERAPEUTICS, INC. (US) 1996-07-03 EP disclosed
EP-0719267-A4 SECOND MESSENGER CELL SIGNALING INHIBITORS CELL THERAPEUTICS INC (US) 1996-02-16 EP disclosed
WO-1994022863-A1 SECOND MESSENGER CELL SIGNALING INHIBITORS CELL THERAPEUTICS, INC. (US) 1994-10-13 WO disclosed